Anti-malarial drug for high-risk people
New Delhi, March 25 -- The anti-malarial drug hydroxychloroquine has been approved by the national task force of the Indian Council of Medical Research (ICMR) as a prophylaxis - treatment to prevent disease - for people at high risk of contracting Covid-19, according to the Union ministry of health....
To read the full article or to get the complete feed from this publication, please
Contact Us.